(1 - 13 from 13
)
LUMC talent Edouard Fu receives NWO Rubicon grant to conduct ...lumcglobal.nl › news-updates › lumc-talent-edouard-fu-receives-nwo-rubic...
lumcglobal.nl
Oct 6, — The project will be led by Professor Paul Quax, Head of Experimental Vascular Surgery at the LUMC, to support accelerated development of ...
17th International Symposium on Atherosclerosis ...
healthmanagement.org
Paul Quax. ******@gmail.com. Professor of Vascular Surgery - Leiden University Medical Center. Harry Buller. ******@gmail.com. Professor of Internal Medicine ...
---> Our Hot NASDAQ First Class Alert Inside. The Start of a Much...
newsletter.hotstocked.com
The studies were conducted by Professor Paul Quax, Ph.D., and Yael Nossent, Ph.D., of the Department of Surgery, Einthoven Laboratory for ...
Idera Announces Presentation on Preclinical Studies of TLR Antagonist...
ir.iderapharma.com
... presentation of preclinical data indicating that its dual antagonist of Toll-like receptor (TLR) 7 and TLR9 reduced restenosis and atherosclerosis in a mouse model of hypercholesterolemia. The studies were conducted in collaboration with Professor Paul Quax , Ph.D., from the Department of Surgery , Einthoven Laboratory ...
sorted by relevance / date